Purchase Decision Follows One Year Extensive Competitive Evaluation Process DENVER, May 14 /PRNewswire-FirstCall/ -- Wyndgate Technologies(R), a division of Global Med Technologies(R), Inc. (OTC:GLOB) (BULLETIN BOARD: GLOB) , today announced that Hackensack University Medical Center (HUMC), one of the nation's premier university-based teaching hospitals, has purchased both SafeTrace(R) software to manage its donor center and SafeTrace Tx(R) software to manage its transfusion service, making it Wyndgate's newest Vein-to-Vein(R) client. Terms of the agreement were not disclosed. (Logo: http://www.newscom.com/cgi-bin/prnh/20040226/GLOBALMEDLOGO ) Hackensack University Medical Center, with a budget of over $1 billion, is affiliated with The University of Medicine and Dentistry of New Jersey-New Jersey Medical School. HUMC is the largest provider of inpatient and outpatient services in the state of New Jersey and the fourth largest provider of inpatient services in the nation based on admissions. Kathleen A. Reilly, MT(ASCP)SM, Administrative Director, Pathology at HUMC, stated, "We believe that selecting an information system is a major decision and, as such, we have been very thorough in our selection process. We evaluated Wyndgate Technologies for over a year and during that time we have gotten to know the company's people and the company's products. We have found Wyndgate to be responsive and informative. They are attentive and customer-focused. Wyndgate's SafeTrace and SafeTrace Tx* software systems are well-designed and we believe they will meet the diverse needs of our large operation. We look forward to working with the company and implementing our new systems." Thomas F. Marcinek, President of Wyndgate Technologies, commented, "Hackensack University Medical Center is a vital nucleus for healthcare in northern New Jersey and the New York metropolitan area. HUMC recognizes this essential role and its need for a system that can meet its current needs and help it continue to keep abreast of changing regulations." Mr. Marcinek continued, "HUMC examined the entire market and took a considerable amount of time to evaluate its leading choices. In light of this thoroughness, Wyndgate is particularly proud to have been selected by HUMC, which demonstrates their confidence in SafeTrace and SafeTrace Tx." About Hackensack University Medical Center HealthGrades recently named Hackensack University Medical Center as one of America's 50 Best Hospitals for 2007. This designation, which is new this year, recognizes hospitals that have demonstrated superior clinical quality over a seven-year time period, based upon an analysis of more than 75 million Medicare patient records from 1999-2005. These hospitals have achieved better survival rates and lower complication rates across dozens of medical procedures and diagnoses, from cardiac care to orthopedic surgery, consistently ranking among the top five percent in the nation for overall clinical outcomes. Hackensack University Medical Center is the only healthcare facility in New Jersey, New York, and New England to be named one of America's 50 Best Hospitals. About Global Med Technologies, Inc. Global Med Technologies, Inc. is an international e-Health medical information technology company providing information management software products and services to the healthcare industry. Its Wyndgate Technologies division is a leading supplier of information management systems to U.S. and international blood centers and hospital transfusion centers. Each year, Wyndgate's products and services manage more than eight million blood components, representing over 27% of the U.S. blood supply. Wyndgate's products are being used in Canada and sub-Saharan Africa, and are being implemented in the Caribbean. Together, the SafeTrace Tx(R) advanced transfusion management system and the SafeTrace(R) donor management system provide Vein-to-Vein(R) tracking from donor collection to patient transfusion. For more information about Global Med's products and services, please call 800-WYNDGATE or visit http://www.globalmedtech.com/, http://www.peoplemed.com/ and http://www.wyndgate.com/. This news release may include statements that constitute forward-looking statements, usually containing the words "believe," "estimate," "project," "expects" or similar expressions. These statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Forward-looking statements inherently involve risks and uncertainties that could cause actual results to differ materially from the forward-looking statements. By making these forward-looking statements, the Company undertakes no obligation to update these statements for revisions or changes after the date of this news release. http://www.newscom.com/cgi-bin/prnh/20040226/GLOBALMEDLOGO http://photoarchive.ap.org/ DATASOURCE: Global Med Technologies, Inc. CONTACT: Michael I. Ruxin, M.D. of Global Med Technologies, Inc., +1-303-238-2000; or Investors, Paul Holm, +1-212-888-4570, for Global Med Technologies, Inc. Web site: http://www.peoplemed.com/ Web site: http://www.wyndgate.com/ Web site: http://www.globalmedtech.com/

Copyright